Magazine Article | September 3, 2018

One-On-One With Tony Coles, CEO Of Yumanity Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

While in Boston for the 2018 BIO International Convention, I escaped the hustle and bustle of the show for a few hours to interview an executive whom I had wanted to meet for years — Tony Coles, M.D. The interview took place in Cambridge at the small, understated offices of Yumanity Therapeutics, a biotech launched in December of 2014 that focuses on therapies for Alzheimer's, Parkinson's, and ALS. Coles, the company's chairman and CEO, met me wearing a black mock turtleneck, jeans, and his trademark round-framed glasses.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: